SPOTLIGHT: FDA approves FluMist for young children


The FDA has approved MedImmune's no-needle FluMist vaccine for use in kids as young as 2; previously it could only be used in children 5 years and older. This is good news for MedImmune (and its new parent AstraZeneca), which has struggled to make FluMist a success since the drug was approved in 2003. Release

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.